Mitsubishi Chemical Holdings Corporation

07/07/2022 | Press release | Distributed by Public on 07/06/2022 19:07

Eli Lilly Japan and Mitsubishi Tanabe Pharma Corporation signed a sales collaboration agreement in Japan for GIP/GLP-1 receptor agonist “Tirzepatide”NEW

Mitsubishi Tanabe Pharma Corporation, a member of the Mitsubishi Chemical Group,
has announced the following press release.

■Mitsubishi Tanabe Pharma　Press Release

Eli Lilly Japan and Mitsubishi Tanabe Pharma Corporation signed a sales collaboration agreement in Japan for GIP/GLP-1 receptor agonist "Tirzepatide"

https://www.mt-pharma.co.jp/e/news/assets/pdf/e_MTPC220411.pdf